Skip to content
Screener

PP&E (Net) at other companies

Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$263K-53.8%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$3.84M+1.0%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$9.76M+122%
Alumis Inc. logo
Alumis Inc.ALMS
$17.53M-13.7%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$39.97M-17.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.46B

Other financials

Income statement

See full
Revenue$700.0K-53.3%
Operating income-$50.6M-23.1%
Net income-$50.4M-20.3%
EPS (diluted)-$0.12+61.3%

Balance sheet

See full
Cash & equivalents$174.9M+69.5%
Total debt$7.7M+0.1%
Total equity$160.4M+86.1%
Total assets$223.2M+55.6%

Cash flow

See full
Operating cash flow-$52.6M-55.2%
CapEx$400.0K
Free cash flow-$53.0M-56.3%

Valuation

See full
Market cap$847.16M+218%
Enterprise value$679.96M+297%
P/S168.8×+100×

Profitability

See full
Operating margin-3,543.1%+523pp
Net margin-3,506.5%+442pp
FCF margin-3,399.3%+3,268pp

Returns & leverage

See full
Return on equity-142.7%-5.0pp
Debt / equity0.0×
Current ratio3.7×+1.3×

Where this comes from

Reported directly by DBV Technologies in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: DBV Technologies’s 10-Q, filed July 16, 2026.

Filed
Jul 16, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-048453
Line itemNoteJune 30, 2026December 31, 2025
Cash and cash equivalents3174.9194.2
Other current assets527.018.8
Total current assets201.9212.9
Property, plant, and equipment, net49.710.4
Right-of-use assets65.94.6
Other non-current assets55.85.8
Total non-current assets21.320.8
Total Assets223.2233.7

Item 1C. Condensed Consolidated Statements of Financial Position (Unaudited) as of

FAQ

What is DBV Technologies's PP&E (net)?
DBV Technologies (DBVT) reported PP&E (net) of $9.7M in Q2 2026.
How has DBV Technologies's PP&E (net) changed year-over-year?
DBV Technologies's PP&E (net) decreased by 12.3% year-over-year, from $11.06M to $9.7M.
What is the long-term trend for DBV Technologies's PP&E (net)?
Over 5 years (2020 to 2025), DBV Technologies's PP&E (net) has grown at a -15.9% compound annual growth rate (CAGR), from $24.79M to $10.4M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about DBV Technologies's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude